Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
复制标题
DOI:
10.1161/01.cir.94.11.2743
复制
发表时间:
1996-12-01
期刊:
影响因子:
37.8
通讯作者:
Jacobsen, DW
中科院分区:
文献类型:
--
作者:
Robinson, K;Gupta, A;Jacobsen, DW
Background A high level of total plasma homocysteine is a risk factor for atherosclerosis, which is an important cause of death in renal failure. We evaluated the role of this as a risk factor for vascular complications of end-stage renal disease.Methods and Results Total fasting plasma homocysteine and other risk factors were documented in 176 dialysis patients (97 men, 79 women; mean age, 56.3+/-14.8 years). Folate, Vitamin B-12, and pyridoxal phosphate concentrations were also determined. The prevalence of high total homocysteine Values was determined by comparison with a normal reference population, and the risk of associated Vascular complications was estimated by multiple logistic regression. Total homocysteine concentration was higher in patients than in the normal population (26.6+/-1.5 versus 10.1+/-1.7 mu mol/L; P95th percentile for control subjects, 16.3 mu mol/L) were seen in 149 patients (85%) with end-stage renal disease (P27.8 mu mol/L) had an independent odds ratio of 2.9 (CI, 1.4 to 5.8; P=.007) of vascular complications. B vitamin levels were lower in patients with vascular complications than in those without. Vitamin Bg deficiency was more frequent in patients than in the normal reference population (18% versus 2%; P